Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Regular Treatment With Long Acting Beta Agonists Versus Daily Regular Treatment With Short Acting Beta Agonists in Adults and Children With Stable Asthma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431072/all/repview. Accessed 16 May 2024.
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431072/all/repview. Accessed May 16, 2024.
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431072/all/repview
Regular Treatment With Long Acting Beta Agonists Versus Daily Regular Treatment With Short Acting Beta Agonists in Adults and Children With Stable Asthma [Internet]. In: Cochrane Abstracts. [cited 2024 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431072/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma
ID - 431072
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431072/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -